A federal appeals court has overturned the corruption conviction of former New York Assembly Speaker Sheldon Silver.
NYS Entity Status
NYS Filing Date
JUNE 03, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2014 - MIND, BODY, SPIRIT SPEAKERS BUREAU, CORP.
2014 - MIND BODY SPIRIT SPEAKERS BUREAU, CORP.
Around the Web
- Conviction Overturned for ex-NY Assembly Speaker Sheldon Silver
Thursday Jul 13, 2017
- Does Electroconvulsive Therapy Improve Huntington’s Disease?
Wednesday Jul 19, 2017
For over 70 years Electroconvulsive Therapy (ECT) has been used to treat severe depression and there are reports that it could help patients with Huntington’s Disease who experience psychiatric symptoms. Many patients with Huntington’s Disease experience depression, with suicide rates 5 to 10 times higher than the general public. In 21 published case reports where -
- UTA Acquires Speakers Bureau Greater Talent Network
By Thom Geier, provided by
- Tuesday Sep 12, 2017
United Talent Agency has acquired Don Epstein’s 35-year-old speakers bureau Greater Talent Network, the companies announced Tuesday.Terms of the deal were not disclosed. Epstein, who launched GTN in the basement of a New York brownstone in 1982 by signing initial clients P.J. O’Rourke and Tom Wolfe, will become a partner in UTA as part of the deal.GTN boasts some of the top lecture agents and professional event coordinators representing talent from the worlds of business, entertainment, sports, media, technology, news and politics. GTN will continue to operate out of its New York City and Florida offices.
- MSH3 Gene Reveals Critical Link With Huntington’s Disease
Wednesday Aug 9, 2017
A recent study published in Lancet Neurology reveals important associations between MSH3 gene mutations and Huntington’s disease progression and disease burden.
- The Link Between Huntington’s Disease and Brain Structure
Wednesday Sep 6, 2017
Scientists at Northwestern University have discovered a link between Huntington’s Disease and dysfunction of the brain’s structure. These finding may explain the causes of the debilitating symptoms and loss of brain tissue as the disease progresses. Currently, it is not understood why the mutation of a specific gene leads to expression of symptoms and loss -